APE1 gene silencing promotes the sensitivity of osteosarcoma U2-OS cells to bortezomib

Chinese Journal of Clinical Oncology

Volumn 39, Issue 8, 2012, Pages 429-432

  Duo, Jian ^a   Wang, Guowen ^a   Han, Xiuxin ^a   Yang, Jilong ^a   Sun, Jianhe ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Apurinic apyrimidinic endonuclease 1; NF B protein; Osteosarcoma; Proteasome inhibitor

Indexed keywords

APURINIC ENDONUCLEASE 1; BORTEZOMIB; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84862142044     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2012.08.003     Document Type: Article

References (12)

1. Montagut C, Rovira A, Albaneil J. The proteasome:a novel target for anticancer therapy[J]. Clin Transl Oncol, 2006, 8(5): 313-317.
2. Andrew F, Cun-Yu W. Proteasome Inhibitor Induces Apoptosis through Induction of Endoplasmic Reticulum Stress[J]. Cancer Biol Ther, 2006, 5(7): 745-748.
3. Yang M, Huang J, Pan HZ, et al. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB padiways in human multiple myeloma cells[J]. International journal of moLecular medicine, 2008, 22(4): 489-496.
4. Hideshima T, Ikeda H, Chauhan D, et al. Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells[J]. Blood, 2009, 114(5): 1046-1052.
5. Chauhan D, Hideshima T, Mitsiades C. Proteasome inhibitor therapy in multiple myeloma[J]. MoL Cancer Ther, 2005, 4(4): 686-692.
6. Shapovalov Y, Benavidez D, Zuch D, et al. Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma[J]. Int J Cancer, 2010, 127(1): 67-76.
7. Yang JL, Yang D, Cogdell D, et al. APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence,Metastasis, and Survival[J]. Technology in Cancer Research and Treatment, 2010, 9(2): 161-169.
8. Wang D, Xiang DB, Yang XQ, et al. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells[J]. Lung Cancer, 2009, 66(3): 298-304.
9. Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APEl) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APEl expression inhibition[J]. MoL Cancer Ther, 2004, 3(6): 679-683.
10. Flaherty DM, Monick MM, Huuninghake GW, et al. AP Endonucleases and the Many Functions of Ref-1[J]. Am J Respir Cell MoL Biol, 2001, 25(6): 664-667.
11. Guan Z, Basi D, Li Q, et al. Loss of redox factor 1 decreases NF-kappaB activity and increases susceptibility of endothelial cells to apoptosis. Arterioscler[J]. Arterioscler Thromb Vasc Biol, 2005, 25(1): 96-101.